EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pan-Cancer Molecular Biomarkers

Fei Dong

Clinics in Laboratory Medicine · 2024-06 · 44 (2) · 325-337

DOI: 10.1016/j.cll.2023.08.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Laboratory Medicine, 2024-06. Verfasst von Fei Dong. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, 3375 Hillview Ave, Palo Alto, CA 94304, USA. Electronic address: feidng@stanford.edu. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid adoption of next-generation sequencing in clinical oncology has enabled the detection of molecular biomarkers shared between multiple tumor types. These pan-cancer biomarkers include sequence-altering mutations, copy number changes, gene rearrangements, and mutational signatures and have been demonstrated to predict response to targeted therapy. This article reviews issues surrounding current and emerging pan-cancer molecular biomarkers in clinical oncology: technological advances that enable the broad detection of cancer mutations across hundreds of genes, the spectrum of driver and passenger mutations derived from human cancer genomes, and implications for patient care now and in the near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorNeoplasmsHumansHigh-Throughput Nucleotide SequencingMutation

Stichwörter der Autor:innen

Cancer biomarkersMolecular pathologyNext-generation sequencingTargeted therapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Stanford University School of Medicine, 3375 Hillview Ave, Palo Alto, CA 94304, USA. Electronic address: feidng@stanford.edu.

Zitieren

APA

Dong, F. (2024). Pan-Cancer Molecular Biomarkers. Clinics in Laboratory Medicine, 44(2), 325-337. https://doi.org/10.1016/j.cll.2023.08.013

Vancouver

Dong F. Pan-Cancer Molecular Biomarkers. Clinics in Laboratory Medicine. 2024;44(2):325-337. doi:10.1016/j.cll.2023.08.013

BibTeX
@article{Dong2024,
  author = {Dong, Fei},
  title = {Pan-Cancer Molecular Biomarkers},
  journal = {Clinics in Laboratory Medicine},
  year = {2024},
  volume = {44},
  number = {2},
  pages = {325--337},
  doi = {10.1016/j.cll.2023.08.013}
}
Kostenlos starten →